Skip to main content
TipRanks
Go Ultimate75% OFF

Unicycive Therapeutics (UNCY) Ownership - Who Owns Unicycive Therapeutics?

965 Followers

Unicycive Therapeutics (UNCY) Ownership Overview

  • 9.85% Insiders
  • 6.71% Mutual Funds
  • 20.49% Other Institutional Investors
  • 8.74% ETFs
  • 54.21% Public Companies and Individual Investors

The ownership structure of Unicycive Therapeutics (UNCY) stock is a mix of institutional, retail, and individual investors. Approximately 35.94% of the company’s stock is owned by Institutional Investors, 9.85% is owned by Insiders, and 54.21% is owned by Public Companies and Individual Investors.

Institutional holdings as of (latest 13F reporting period).

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue
Jun 30, 2026 $6,628,757

Top Shareholders

UNCY top shareholders
Holder# of SharesType% HoldingValue
Gupta Shalabh K.2,527,449Insider9.07%9,351,561
BlackRock, Inc.1,407,024Institution5.05%5,205,989
Vanguard1,293,152Institution4.64%4,784,662
Vanguard Index Funds1,045,733Institution3.75%3,869,212
Ishares919,643Institution3.30%3,402,679
Fidelity Salem Street Trust293,359Institution1.05%1,085,428
Fidelity Concord Street Trust180,856Institution0.65%669,167
Jermasek Douglas175,012Insider0.63%647,544
Vanguard Scottsdale Funds168,441Institution0.60%623,232
Spdr117,400Institution0.42%434,380

Top Mutual Fund Holders

UNCY top mutual fund holders
Holder# of SharesType% HoldingValue
Vanguard Index Funds1,045,733Institution3.75%3,869,212
Fidelity Salem Street Trust293,359Institution1.05%1,085,428
Fidelity Concord Street Trust180,856Institution0.65%669,167
Vanguard Scottsdale Funds168,441Institution0.60%623,232
Schwab Capital Trust54,842Institution0.20%202,915
Tiaa-cref Funds33,059Institution0.12%122,318
Dfa Investment Dimensions Group Inc27,203Institution0.10%100,651
Vanguard Institutional Index Funds14,411Institution0.05%53,321
Vanguard Valley Forge Funds11,337Institution0.04%41,947
Valic Co I10,680Institution0.04%39,516

Top ETF Holders

UNCY top ETF holders
Holder# of SharesType% HoldingValue
Vanguard Total Stock Market ETF, VTI ETF634,932Institution2.28%2,374,646
iShares Russell 2000 ETF, IWM ETF617,560Institution2.22%2,192,338
Vanguard Extended Market ETF, VXF ETF317,687Institution1.14%1,188,149
iShares Russell 2000 Growth ETF, IWO ETF204,066Institution0.73%724,434
Vanguard Russell 2000 ETF, VTWO ETF144,711Institution0.52%541,219
iShares Micro-Cap ETF, IWC ETF74,430Institution0.27%275,391
State Street SPDR RUSSELL 2000 U.S. SMALL CAP UCITS ETF Accum Shs - Hedged EUR, FR:R2EH ETF58,700Institution0.21%213,668
Goldman Sachs Activebeta U.S. Small Cap Equity ETF, GSSC ETF42,954Institution0.15%158,930
iShares Russell 2000 Value ETF, IWN ETF23,623Institution0.08%87,405
Vanguard Russell 2000 Growth ETF, VTWG ETF23,395Institution0.08%87,497

FAQ

Who Owns Unicycive Therapeutics (UNCY)?
According to the latest TipRanks data (13F holdings as of June 30, 2026), approximately 35.94% of the company's stock is held by institutional investors, 9.85% is held by insiders, and 54.21% is held by public companies and individual investors.
What percentage of Unicycive Therapeutics (UNCY) stock is held by institutional investors?
According to the latest TipRanks data (13F holdings as of June 30, 2026), approximately 35.94% of Unicycive Therapeutics (UNCY) stock is held by institutional investors: 6.71% by mutual funds, 8.74% by ETFs and 20.49% by other institutional investors.
What percentage of Unicycive Therapeutics (UNCY) stock is held by retail investors?
According to the latest TipRanks data (13F holdings as of June 30, 2026), approximately 54.21% of Unicycive Therapeutics (UNCY) stock is held by public companies and individual investors.
Who owns the most shares of Unicycive Therapeutics (UNCY)?
Gupta Shalabh K. owns the most shares of Unicycive Therapeutics (UNCY).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.